Associated Papers
Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.
Mondejar R et al.
Plos One, 2017
28505169 (PubMed )
Supplement: pone.0177524.s005.xlsx › Supplementary_table_5
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
Kiel MJ et al.
Nature Communications, 2015
JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations.
Ren Y et al.
Scientific Reports, 2013
24154688 (PubMed )
Supplement: srep03042-s1.pdf
Select a paper to view details